SUO 2015 - Results from #20

Viewing 21-40 of 40 articles

SUO 2015 Designing the next generation of clinical trials - Session Highlights

SUO 2015 Current Use of Imaging for Penile Cancer Management - Session Highlights

SUO 2015 Currently Available Genomic Tools for Risk Stratification of Localized Prostate Cancer - Session Highlights

SUO 2015 INPACT Trial Update - Session Highlights

SUO 2015 Huggins Medal Lecture - Session Highlights

SUO 2015 Accessing Genomic Data in Prostate Cancer: Overview of TCGA Subtypes - Session Highlights

SUO 2015: Heterogeneity in Prostate Cancer - Session Highlights

SUO 2015 PD-1 expression on Classical Monocytes (CM) is an independent predictor of cancer specific survival in clear cell Renal Cell Carcinoma - Poster Session

SUO 2015 Surgical Coaching for Performance Improvement - Session Highlights

SUO 2015 Putting the “PATIENT” into Patient-centered Outcomes Research Prioritization - Session Highlights

SUO 2015 Emerging therapies for patients with bladder cancer - Session Highlights

SUO 2015 - New approaches to adjuvant therapy for muscle-invasive bladder cancer - Session Highlights

SUO 2015 - Venous thromoboembolism following nephrectomy: thirty day incidence and risk factors from national multi-institutional data - Poster Session Highlights

SUO 2015 - Systemic Therapy in UTUC: Chemotherapy in the renal impaired - Session Highlights

SUO 2015 - Systemic Therapy in UTUC: The Role of Checkpoint Blockade Therapies - Session Highlights

SUO 2015 - Systemic Therapy in UTUC: Neoadjuvant Treatment: Standard of Care? - Session Highlights

SUO 2015 Lynch Syndrome in UTUC: Significance, Screening, and Surveillance - Session Highlights

SUO 2015 - Variant Morphology in Bladder Cancer: Updates and Controversies - Session Highlights

SUO 2015 Aggressive Variant Prostate Carcinomas: “Beyond Morphologic Characterization” - Session Highlights

SUO 2015 - Intermediate Atypical Carcinoma: A New CRPC Entity - Session Highlights

1
2